Announcement under Regulation 30 (LODR)-Newspaper Publication
Filed with BSE · · 3 pages · English
Summary by 6ix AI
The financial results indicate a loss for the period before and after tax, compared to a profit in the same period last year. The filing also notes that the results have been reviewed by the Audit Committee and approved by the Board of Directors.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Aspira Pathlab & Diagnostics Ltd. on 6ix
Earlier from Aspira Pathlab & Diagnostics
- Financial Result For Half Year Ended 30Th September 2026
- Board Meeting Outcome for Outcome Of Board Meeting Dated 6Th November 2026
- Board Meeting Intimation for Board Meeting To Be Held On November 06, 2026 For The Second Quarter/Half Year Ended September 30, 2026
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
- Aspira Pathlab & Diagnostics Ltd. Press Release Oct 01 2026
Follow Aspira Pathlab & Diagnostics into a list and get an email when it puts out news.
Follow Aspira Pathlab & Diagnostics